	Familial papillary thyroid cancer; A male case with breast and thyroid cancer and his three sisters with thyroid cancer: A case series and review of the literature. Indian J Cancer F, Durhan A. PMID: 41797593 [PubMed - indexed for MEDLINE]
	Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. Indian J Cancer Sandeep KS, Appachu S, Diwaker RB, Vivek S, Simha VVS. PMID: 41797591 [PubMed - indexed for MEDLINE]
	The phase III MECCA study on metronomic chemo-endocrine therapy in advanced breast cancer-the results that so many have been waiting for. Chin Clin Oncol Wysocki PJ. PMID: 41797464 [PubMed - in process]
	Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review. Chin Clin Oncol Sánchez Díaz E, Levin G, Fernandes A, Fletcher A, Pareja R. PMID: 41797457 [PubMed - indexed for MEDLINE]
	Radiomics-driven prediction of pathologic complete response in non-mass breast cancer using post-neoadjuvant chemotherapy preoperative dynamic contrast-enhanced magnetic resonance imaging. Diagn Interv Radiol Moroz O, Liu Z, Liu C, Yin Q, Li X, Ai T. PMID: 41797338 [PubMed - as supplied by publisher]
	PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan. J Gynecol Oncol Chao WT, Sung YW, Huang KJ, Yeh LS, Sheu BC, Chang WC, Peng SH, Lin PH, Wang PH. PMID: 41796994 [PubMed - as supplied by publisher]
	Impact of prior olaparib use on subsequent platinum-based therapy in recurrent ovarian cancer. J Gynecol Oncol Ono K, Kobayashi Y, Shikama A, Irie G, Yoshino M, Tsuihiji A, Isayama M, Takeuchi K, Kuboya T, Fujieda K, Suto A, Tenjimbayashi Y, Akiyama A, Nakao S, Minaguchi T, Satoh T. PMID: 41796993 [PubMed - as supplied by publisher]
	Evaluation of preoperative lymphatic drainage imaging using indocyanine green for precise sentinel lymph node biopsy in breast cancer patients. Curr Probl Surg Li X, Wang Y, Wu Y, Liang Y, Kong X, Ma T, Jiang L, Yang Q. PMID: 41796520 [PubMed - indexed for MEDLINE]
	Completion vs. early discontinuation of chemotherapy and the impact on 5-year all-cause mortality in women treated for early-stage breast cancer from 2015 to 2020: A cohort study using a target trial emulation approach. Br J Clin Pharmacol Steventon L, Ju C, Man KKC, Roylance R, Ottaviani D, Creed C, Sladkowski M, Wisner A, Wei L, Chambers P. PMID: 41796085 [PubMed - as supplied by publisher]
	Efficacy and safety of electrochemotherapy in the treatment of cutaneous and sub-cutaneous recurrence from breast cancer: A single-center cohort study. Eur J Surg Oncol Sena G, Amaddeo A, Iannello A, Renne M, Orsini V, Currò G, Rizzuto A. PMID: 41795433 [PubMed - as supplied by publisher]
	Liposome-based nanocarriers for Ovarian cancer: Molecular targeting, therapeutic mechanisms, and clinical translation. Colloids Surf B Biointerfaces Raies S, Rehman U, Gupta G, Alsayari A, Wahab S, Goh KW, Kesharwani P. PMID: 41795321 [PubMed - as supplied by publisher]
	Evaluating perioperative self-reported sleep quality in patients with a gynecologic malignancy. Support Care Cancer Desai RM, Silberman J, Reasner E, Grubbs A, Bilimoria K, Barber EL. PMID: 41795006 [PubMed - indexed for MEDLINE]
	5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial. Lancet Rivera S, Ghodssighassemabadi R, Auzac G, Brion T, Kirova Y, Racadot S, Benchalal M, Clavier JB, Charra Brunaud C, Groulier A, Argo-Leignel D, Peignaux K, Benyoucef A, Pasquier D, Guilbert P, Goineau A, Tallet A, Bergeaud M, Lamrani-Ghaouti A, Michiels S, HypoG-01 trialists. PMID: 41794436 [PubMed - indexed for MEDLINE]
	An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer. Int J Biol Macromol Ma H, Li T, Huang R, Liu Y, Zhao L, Zhuang Z. PMID: 41794244 [PubMed - as supplied by publisher]
	Disparities in Diagnosis, Treatment, and Outcomes of Early-Onset Breast Cancer: A Global Perspective. Crit Rev Oncol Hematol Chinedu SN, Ogbodo PN, Effiong ME. PMID: 41794162 [PubMed - as supplied by publisher]
	From Antigen to Atlas: A Multi-omics, Single-Cell Pipeline for Discovering Safe and Effective CAR Targets in Ovarian Cancer. Crit Rev Oncol Hematol Khand FM, Lakho SA, Leghari A. PMID: 41794160 [PubMed - as supplied by publisher]
	Prognostic Significance of miR-145, NANOG, OCT4, and KLF4 in Triple-Negative Breast Cancer. Asian Pac J Cancer Prev Sameh R, Hussein S, Ibrahim AA, Waley AB, Ibrahim SM, Bedawy AM, Siam M, Abdelgeleel HM. PMID: 41793693 [PubMed - indexed for MEDLINE]
	Schlafen 11 (SLFN11) And Tumor-Infiltrating Lymphocytes (TILs): Dual Predictive Biomarkers In Ovarian Serous Carcinoma. Asian Pac J Cancer Prev Michael SR, Badary DM, Abou-Taleb HA, Gamal DA, Mumdouh RM, Nazeer YAF, Nassar MI. PMID: 41793692 [PubMed - indexed for MEDLINE]
	Analysis of In-Vivo Dose Measurement of Urethra Using Array MOSFET Detectors and TPS-Calculated Dose in High-Dose-Rate Interstitial Brachytherapy in Gynaecological Malignancies. Asian Pac J Cancer Prev Sushma N, C R TP, Y S N, Kaginelli S, Palanivel S, K R N, M V M, K M G. PMID: 41793688 [PubMed - indexed for MEDLINE]
	PIK3CA Polymorphisms in Cervical Cancer: Differential Impact of rs6443624 and rs141178472. Asian Pac J Cancer Prev Srivastava H, Raghuvanshi S, Bhalla S, Raghuvanshi S, Singh A, Singh AK, Singh N, Nigam N, Sonkar GK, Iqbal Z, Prakash S. PMID: 41793685 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 325432

Page 1 of 16272



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy